Active Ingredient(s): Lonafarnib
FDA Approved: * November 20, 2020
Pharm Company: * EIGER BIOPHARMS
Category: Genetic Disorders

Lonafarnib, sold under the brand name Zokinvy, is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in people one year of age and older.[2][3] The most common side effects included nausea vomiting, headache ,diarrhea, infection, decreased appetite and fatigue.[2] Lonafarnib was approved for medical use in the United States in Nov... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.